hPG<sub>80</sub> (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors

hPG<sub>80</sub> (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors

Current blood-based biomarkers for neuroendocrine neoplasms (NENs) lack both sensitivity and specificity. Human circulating progastrin (hPG<sub>80</sub>) is a novel biomarker that can be easily measured in plasma by ELISA. This study is the first to examine hPG<sub>80</sub> i...

Full description

Bibliographic Details
Main Authors: Aman Chauhan, Alexandre Prieur, Jill Kolesar, Susanne Arnold, Léa Payen, Younes Mahi, Berengere Vire, Madison Sands, B. Mark Evers, Dominique Joubert, Lowell Anthony
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Cancers
Subjects:
circulating progastrin
hPG<sub>80</sub>
blood-based diagnostic biomarker
neuroendocrine neoplasms
neuroendocrine tumors
neuroendocrine carcinoma
Online Access:https://www.mdpi.com/2072-6694/14/4/863

Internet

https://www.mdpi.com/2072-6694/14/4/863

Similar Items